The psychiatric drug industry and Big Tobacco share striking similarities in their tactics, particularly when it comes to downplaying the risks associated with their products and targeting vulnerable populations like youths. The psychiatric community has gotten away with pretending it is based in science and medicine to sell its snake oil, whereas the tobacco industry wasn’t so lucky.
A key difference lies in the government's stance — whereas tobacco companies face increasing regulations and warnings, the psychiatric drug industry enjoys substantial government support and promotion despite the existence of black box warnings on many of its medications. Both industries have a history of misleading marketing practices and minimizing potential harms.
No comments:
Post a Comment
All comments are moderated due to spam, drunks and trolls.
Keep 'em civil, coherent, short, and on topic.